Tenofovir Disoproxil 300 mg + Lamivudine 300 mg Tablet – Manufacturer, Supplier & PCD Franchise



Tenofovir Disoproxil 300 mg + Lamivudine 300 mg Tablet — available for PCD franchise from Trumac Healthcare

Tenofovir Disoproxil 300 mg + Lamivudine 300 mg Tablet

Tenofovir Disoproxil 300 mg + Lamivudine 300 mg — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing

Composition: Tenofovir Disoproxil 300 mg + Lamivudine 300 mg
Form: Tablet
Class: Nucleoside Reverse Transcriptase Inhibitor (NRTI) — Antiretroviral
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ Available Now

Pricing, brochure & monopoly territory within 24 hrs.

Tenofovir Disoproxil 300 mg + Lamivudine 300 mg Tablet is available from Trumac Healthcare, a PCD pharma franchise company and supplier in India whose products are made at WHO-GMP certified partner units. This tablet formulation is offered on monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing basis across all Indian states. We already supply Tenofovir Disoproxil across our existing range, so supply is established and lead times are short.

Therapeutic Indications
  • HIV-1 infection in adults and adolescents, as part of combination antiretroviral therapy (cART)
  • Component of WHO and NACO India first-line ART regimens
  • Used in fixed-dose combinations with other antiretrovirals
Mechanism of Action

After intracellular phosphorylation to its active triphosphate form, this nucleoside analogue competes with natural nucleotides for incorporation into the viral DNA chain by HIV-1 reverse transcriptase.

Once incorporated, it terminates DNA chain elongation because it lacks the 3'-hydroxyl group required for further nucleotide linkage, thereby suppressing HIV-1 replication and reducing plasma viral load.

Dosage & Administration
  • Dosage of Tenofovir Disoproxil 300 mg + Lamivudine 300 mg Tablet must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
  • Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
  • Do not exceed the prescribed dose, and complete the full course as advised.
  • Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
  • To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
  • Nausea, vomiting, diarrhoea
  • Headache, fatigue
  • Lactic acidosis with hepatic steatosis (class effect, rare but serious)
  • Lipoatrophy with long-term use
  • Elevated liver enzymes
Contraindications
  • Hypersensitivity to the drug or any excipient
  • Severe hepatic impairment
  • Never use as monotherapy — always combine with at least 2 other active antiretrovirals
  • Pregnancy/lactation only under specialist supervision
Storage

Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.

Part of our PCD pharma franchise range, available on a monopoly basis – see the general range PCD franchise product list (PDF). See our full tablets PCD pharma franchise. Comparing companies? See the general range PCD companies compared. No franchise fee; minimum first order ₹25,000 – cost and documents.


See the full antiviral range – manufacturer, supplier and PCD franchise: hepatitis B, herpes and shingles, influenza and HIV antiviral compositions.

PCD Pharma Franchise & Third Party Manufacturing — Tenofovir Disoproxil + Lamivudine Tablet

  • ✓ Made at WHO-GMP certified partner units — every batch QC released
  • ✓ Monopoly PCD franchise rights at district or state level
  • ✓ Third party / contract manufacturing under your own brand
  • ✓ Wholesale and distributor supply against drug licence + GST
  • ✓ Attractive net rates with healthy PTR / PTS margins
  • ✓ Dispatch within 48 hours of payment realisation

Composition: Tenofovir Disoproxil 300 mg + Lamivudine 300 mg. Trumac Healthcare supplies this nrti antiretroviral with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.

PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Tenofovir Disoproxil + Lamivudine Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.

Frequently Asked Questions

Who manufactures Tenofovir Disoproxil + Lamivudine Tablet in India?

Trumac Healthcare is a supplier of Tenofovir Disoproxil + Lamivudine Tablet in India; products are made at WHO-GMP certified partner units. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.

Is Tenofovir Disoproxil + Lamivudine Tablet available for PCD pharma franchise on monopoly basis?

Yes. Tenofovir Disoproxil 300 mg + Lamivudine 300 mg Tablet is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.

Do you offer Tenofovir Disoproxil + Lamivudine for third party or contract manufacturing?

Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Tenofovir Disoproxil + Lamivudine Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.

Can Tenofovir Disoproxil + Lamivudine Tablet be supplied on wholesale or distributor basis?

Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.

What is the therapeutic class of Tenofovir Disoproxil + Lamivudine?

Tenofovir Disoproxil + Lamivudine is classified as a NRTI Antiretroviral — Nucleoside Reverse Transcriptase Inhibitor (NRTI) — Antiretroviral.

What documentation is provided with each supply?

Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.

How quickly can an order be dispatched?

Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.

Is a prescription required for Tenofovir Disoproxil + Lamivudine Tablet?

Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.

Ready to start your PCD franchise for Tenofovir Disoproxil 300 mg + Lamivudine 300 mg Tablet?

Get Pricing & Franchise Terms →